Step 1 of 2
Emerging treatment approaches for schizophrenia are expanding beyond traditional dopamine-targeting antipsychotics. These downloadable slides from Psychopharmacology Update 2026 examine unmet treatment needs, muscarinic receptor pharmacology, and the clinical evidence for approved and investigational muscarinic agents. Explore differences in mechanisms of action, efficacy, tolerability, and practical considerations for integrating novel therapies into individualized schizophrenia management.